Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/08/olin-stock-slides-as-q2-loss-triggers-target-cuts.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

Olin Stock Slides As Q2 Loss Triggers Target Cuts

TIM BOHENUPDATED AUG. 1, 2026, 11:37 AM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Olin Corporation stocks have been trading down by -15.52 percent amid heightened concerns over weakening chemical demand and pricing.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading OLN

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

  • BMO Capital cut its price target on Olin from $30 to $25 while reiterating a Market Perform rating, citing a mixed macro backdrop with weakness in housing and autos and pressure on commodity chemical names into Q2 and the second half.
  • Goldman Sachs reduced its Olin price target from $31 to $24 and reiterated a Neutral rating, warning of downside risk to earnings from Q3 onward due to weaker-than-expected benefits from the Middle East conflict and feedstock-related operational constraints in basic chemicals/MDI.
  • Olin reported a wider Q2 net loss of $0.12 per share versus a $0.01 loss last year, badly missing analyst expectations for a $0.10 profit, with revenue slightly down year over year and below consensus.
  • Following the Q2 earnings release showing EPS of -$0.12 versus the FactSet consensus estimate of +$0.10, Olin shares fell over 5% in after-hours trading.

Candlestick Chart

Weekly Update Jul 27 – Jul 31, 2026: On Saturday, August 01, 2026 Olin Corporation stock [NYSE: OLN] is trending down by -15.52%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Materials industry expert:

Analyst sentiment – negative

Olin’s Q2 profile shows a structurally challenged but not broken franchise. EBITDA margin near 10% this quarter versus ~6% LTM, yet negative net margin and LTM EBIT margin signal weak pricing power and high fixed costs. Revenue is flat to modestly up over five years but down over three, highlighting cyclical stagnation. Leverage is elevated (debt/equity ~1.9x, interest coverage only 2.2x), while free cash flow is negative and working capital is consuming cash, constraining capital allocation flexibility.

Technically, the stock has broken down sharply: a swift drop from 22.19 to an 18.41–18.73 print reflects heavy distribution and failed attempts to hold the low-20s. Intraday 5‑minute candles show persistent selling into bounces with expanding volume on down moves, confirming a bearish short-term trend. The key actionable level is resistance at 21.50–22.00; rallies into that band are sell/short opportunities with a downside trading target near 17.75, just below recent support.

More Breaking News

Fundamentally, Olin just posted a sizable earnings miss (−$0.12 vs +$0.10 expected) with soft revenue, while both BMO and Goldman have cut targets into the mid‑20s and flagged deteriorating macro and feedstock headwinds. Versus broader Materials and Chemicals indices, Olin’s negative earnings momentum, higher leverage, and weaker cash generation justify a discount multiple. I assign a 12‑month fair value range of $18–20, with resistance at $22 and support at $17; risk‑reward is skewed to the downside.

Quick Financial Overview

Olin Corporation just printed a tough Q2, and the tape shows it. The company delivered EPS of -$0.12 versus a -$0.01 loss a year earlier, a sharp miss against the expected +$0.10. Total revenue for the quarter came in at about $1.74B, slightly down year over year and below consensus, confirming that both pricing and volume pressure are now flowing through the income statement. With gross margin around 6.4% and EBIT margin negative at roughly -1.5%, OLN is operating with very thin cushions in a cyclical, commodity-heavy business.

From a balance sheet and cash flow angle, Olin Corporation is still carrying notable leverage. Total debt to equity of 1.91 and a leverage ratio near 4.2 tell traders this is not a low-risk capital structure, especially when operating income is under pressure. Interest coverage of about 2.2 times means higher rates or further earnings erosion could quickly tighten flexibility. Cash flow also flashed caution: operating cash flow of $7.9M against capital spending of $29M drove free cash flow to roughly -$21.1M for the quarter, while $22.8M still went out the door in dividends.

The chart is now reflecting this fundamental stress. On the weekly data, OLN slipped from the low $22s down toward $18.73 into the end of the week, with the most aggressive selloff hitting after earnings. Intraday, a 5-minute candle showing a gap from about $20.48 down toward a $17.73 low before stabilizing near $18.51 signals a classic earnings flush, heavy supply, and likely stop runs below prior support. With price-to-sales around 0.38 and price-to-book near 1.46, valuation screens as cheap, but the market is clearly discounting ongoing margin and demand risk.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders